P4.9 A phase 2, randomized, placebo-controlled, multiple ascending-dose study of ACE-031 (ActRIIB-IgG1) in Duchenne muscular dystrophy (DMD): Preliminary results Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Campbell, C
  • Attie, KM
  • Mah, JK
  • Tarnopolsky, Mark
  • Selby, K
  • McMillan, HJ
  • Yang, Y
  • Wilson, D
  • Barger, R
  • Sherman, ML
  • Escolar, D

publication date

  • October 2011